Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

4(100.0%)

4Total

N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07568782Not Yet Recruiting

Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.

Role: collaborator

NCT07352475Not ApplicableRecruiting

Reasoning Enrichment With Feedback From IA in NEphrology Trial

Role: collaborator

NCT06803446Not ApplicableRecruiting

Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes

Role: lead

NCT06944262Recruiting

Assessment of Cancer-related Post-traumatic Stress in Patients and Caregivers in the Year Following Diagnosis, and Identification of Their Expectations of Personalized Support - CANDYSTRESS

Role: lead

NCT06924463Recruiting

Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry

Role: lead

NCT06832709Not ApplicableNot Yet Recruiting

Fitness and Well-being of Caregivers in the Hauts-de-France Region

Role: lead

NCT06740136Not ApplicableRecruiting

Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS)

Role: lead

All 7 trials loaded